| Home > Institute Collections > BN DZNE > BN DZNE-LIS > Zika crisis in Brazil: challenges in research and development > print |
| 001 | 284092 | ||
| 005 | 20260126112042.0 | ||
| 024 | 7 | _ | |a 10.1016/j.coviro.2016.04.002 |2 doi |
| 024 | 7 | _ | |a 1879-6257 |2 ISSN |
| 024 | 7 | _ | |a 1879-6265 |2 ISSN |
| 037 | _ | _ | |a DZNE-2026-00100 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Secchim Ribeiro, Lucas |0 P:(DE-2719)9001782 |b 0 |u dzne |
| 245 | _ | _ | |a Zika crisis in Brazil: challenges in research and development |
| 260 | _ | _ | |a Amsterdam [u.a.] |c 2016 |b Elsevier |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1769422797_1864 |2 PUB:(DE-HGF) |x Review Article |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Infection with the Zika virus (ZIKV) usually causes a mild acute illness, but two major severe syndromes have been described during the epidemic in Brazil: microcephaly and the Guillain-Barré Syndrome. There is now much evidence to show that ZIKV can infect and damage neuronal cells in vitro. In experimental animals, ZIKV has significant neurotropism and can cause brain damage. At present, diagnosis is still a challenge in the field and there is no treatment available. Another major challenge is that one must devise therapies for pregnant women, at all stages of pregnancy. Devising adequate treatment for ZIKV infections represents a challenge that will only be met by the joint effort of the research community. |
| 536 | _ | _ | |a 899 - ohne Topic (POF4-899) |0 G:(DE-HGF)POF4-899 |c POF4-899 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, Journals: pub.dzne.de |
| 650 | _ | 2 | |a Animals |2 MeSH |
| 650 | _ | 2 | |a Brazil |2 MeSH |
| 650 | _ | 2 | |a Disease Models, Animal |2 MeSH |
| 650 | _ | 2 | |a Female |2 MeSH |
| 650 | _ | 2 | |a Guillain-Barre Syndrome: virology |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Infant, Newborn |2 MeSH |
| 650 | _ | 2 | |a Mice |2 MeSH |
| 650 | _ | 2 | |a Microcephaly: virology |2 MeSH |
| 650 | _ | 2 | |a Pregnancy |2 MeSH |
| 650 | _ | 2 | |a Primates |2 MeSH |
| 650 | _ | 2 | |a Zika Virus: isolation & purification |2 MeSH |
| 650 | _ | 2 | |a Zika Virus: pathogenicity |2 MeSH |
| 650 | _ | 2 | |a Zika Virus Infection: drug therapy |2 MeSH |
| 650 | _ | 2 | |a Zika Virus Infection: immunology |2 MeSH |
| 650 | _ | 2 | |a Zika Virus Infection: therapy |2 MeSH |
| 650 | _ | 2 | |a Zika Virus Infection: virology |2 MeSH |
| 700 | 1 | _ | |a Marques, Rafael Elias |b 1 |
| 700 | 1 | _ | |a Jesus, Amélia Maria Ribeiro de |b 2 |
| 700 | 1 | _ | |a Almeida, Roque Pacheco de |b 3 |
| 700 | 1 | _ | |a Teixeira, Mauro Martins |b 4 |
| 773 | _ | _ | |a 10.1016/j.coviro.2016.04.002 |g Vol. 18, p. 76 - 81 |0 PERI:(DE-600)2611378-8 |p 76 - 81 |t Current opinion in virology |v 18 |y 2016 |x 1879-6257 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/284092/files/DZNE-2026-00100_Restricted.pdf |
| 856 | 4 | _ | |u https://pub.dzne.de/record/284092/files/DZNE-2026-00100_Restricted.pdf?subformat=pdfa |x pdfa |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 0 |6 P:(DE-2719)9001782 |
| 913 | 1 | _ | |a DE-HGF |b Programmungebundene Forschung |l ohne Programm |1 G:(DE-HGF)POF4-890 |0 G:(DE-HGF)POF4-899 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-800 |4 G:(DE-HGF)POF |v ohne Topic |x 0 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CURR OPIN VIROL : 2022 |d 2025-01-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2025-01-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2025-01-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2025-01-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2025-01-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2025-01-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1120 |2 StatID |b BIOSIS Reviews Reports And Meetings |d 2025-01-02 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2025-01-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2025-01-02 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b CURR OPIN VIROL : 2022 |d 2025-01-02 |
| 920 | _ | _ | |l yes |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a I:(DE-2719)1040260 |
| 980 | 1 | _ | |a EXTERN4VITA |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|